scholarly journals Beyond Cholinesterase Inhibition: Developmental Neurotoxicity of Organophosphate Ester Flame Retardants and Plasticizers

2021 ◽  
Vol 129 (10) ◽  
Author(s):  
Heather B. Patisaul ◽  
Mamta Behl ◽  
Linda S. Birnbaum ◽  
Arlene Blum ◽  
Miriam L. Diamond ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-12 ◽  
Author(s):  
Gennaro Giordano ◽  
Lucio G. Costa

The developing central nervous system is often more vulnerable to injury than the adult one. Of the almost 200 chemicals known to be neurotoxic, many are developmental neurotoxicants. Exposure to these compounds in utero or during childhood can contribute to a variety of neurodevelopmental and neurological disorders. Two established developmental neurotoxicants, methylmercury and lead, and two classes of chemicals, the polybrominated diphenyl ether flame retardants and the organophosphorus insecticides, which are emerging as potential developmental neurotoxicants, are discussed in this paper. Developmental neurotoxicants may also cause silent damage, which would manifest itself only as the individual ages, and may contribute to neurodegenerative diseases such as Parkinson’s or Alzheimer’s diseases. Guidelines for developmental neurotoxicity testing have been implemented, but there is still room for their improvement and for searching and validating alternative testing approaches.


2019 ◽  
Vol 167 (1) ◽  
pp. 6-14 ◽  
Author(s):  
Mamta Behl ◽  
Kristen Ryan ◽  
Jui-Hua Hsieh ◽  
Frederick Parham ◽  
Andrew J Shapiro ◽  
...  

Abstract The National Toxicology Program (NTP) receives requests to evaluate chemicals with potential to cause adverse health effects, including developmental neurotoxicity (DNT). Some recent requests have included classes of chemicals such as flame retardants, polycyclic aromatic compounds, perfluoroalkyl substances, and bisphenol A analogs with approximately 20–50 compounds per class, many of which include commercial mixtures. However, all the compounds within a class cannot be tested using traditional DNT animal testing guideline studies due to resource and time limitations. Hence, a rapid and biologically relevant screening approach is required to prioritize compounds for further in vivo testing. Because neurodevelopment is a complex process involving multiple distinct cellular processes, one assay will unlikely address the complexity. Hence, the NTP sought to characterize a battery of in vitro and alternative animal assays to quantify chemical effects on a variety of neurodevelopmental processes. A culmination of this effort resulted in a NTP-hosted collaborative project with approximately 40 participants spanning across domains of academia, industry, government, and regulatory agencies; collaborators presented data on cell-based assays and alternative animal models that was generated using a targeted set of compounds provided by the NTP. The NTP analyzed the assay results using benchmark concentration (BMC) modeling to be able to compare results across the divergent assays. The results were shared with the contributing researchers on a private web application during the workshop, and are now publicly available. This article highlights the overview and goals of the project, and describes the NTP’s approach in creating the chemical library, development of NTPs data analysis strategy, and the structure of the web application. Finally, we discuss key issues with emphasis on the utility of this approach, and knowledge gaps that need to be addressed for its use in regulatory decision making.


2013 ◽  
Vol 2013 (1) ◽  
pp. 5254
Author(s):  
Miyuki Noguchi ◽  
Atsushi Mizukoshi ◽  
Akira Nishimura ◽  
Yukio Yanagisawa ◽  
Akihiro Yamasaki

Sign in / Sign up

Export Citation Format

Share Document